1. ALLA AKTIER
  2. NYHETER
  3. MENDUS

Mendus

Nyheter Mendus Nyheter alla bolag
eToro Trading Platform Advertisement
eToro Trading Platform Advertisement
Slipp dessa annonser och få en massa andra godsaker med vårt premiumabonnemang.

Invitation to second quarter financial report and business update

Mendus AB (“Mendus” publ; IMMU.ST), will publish its interim report for the second quarter 2024 on August 23 at 08.00 CEST. The company will host a live presentation and business update on the same day at 10.00 CEST. The presentation will be held in English and includes a Q&A session.

Date and time: August 23 at 10.00 CEST

If you wish to participate via webcast please use the link below.
https://ir.financialhearings.com/mendus-q2-report-2024

If you wish to participate and ask questions via teleconference, please register on the link below. After registration you will be provided phone numbers and a conference ID to access the conference.
https://conference.financialhearings.com/teleconference/?id=50049744

For more information, please contact:

Erik Manting
Chief Executive Officer
E-mail: ir@mendus.com

About Mendus AB (publ)

Mendus is dedicated to changing the course of cancer treatment by addressing tumor recurrence and improving long-term survival for cancer patients, while preserving health and quality of life. We leverage our understanding of dendritic cell biology to develop an advanced clinical pipeline of immunotherapies which combine clinical efficacy with a benign safety profile. Based in Sweden and The Netherlands, Mendus is publicly traded on the Nasdaq Stockholm under the ticker IMMU.ST. https://www.mendus.com/

Attachments
240815 Mendus 2Q 2024 Invite ENG

Datum 2024-08-15, kl 08:00
Källa MFN
Bifogade filer
240815 Mendus 2Q 2024 Invite ENG